ctrl K

Watchlist Price Alert

Day One Biopharmaceutical... (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

6.90

0.45 (6.98%)

At close: May 12, 2025, 9:35 AM

Day One Biopharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024
License Revenue	73.94M
License Revenue Growth	n/a
Product Revenue	57.22M
Product Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	29.73M	28.97M	30.19M	26.44M	22.17M	18.27M	17.07M	18.03M	16.72M	17.66M	14.16M	12.74M	29.16M	9.39M	5.53M	3.45M	1.98M	1.02M	872K	808K
Selling, General, and Administrative Revenue Growth	+2.63%	-4.02%	+14.16%	+19.27%	+21.31%	+7.05%	-5.30%	+7.80%	-5.33%	+24.75%	+11.09%	-56.29%	+210.47%	+69.99%	+59.96%	+74.53%	+93.26%	+17.43%	+7.92%	n/a
Research and Development Revenue	61.82M	33.56M	92.11M	40.21M	37.35M	33.16M	32.18M	27.83M	26.02M	22.04M	22.56M	15M	43.58M	9.85M	9.91M	12.63M	4.17M	2.54M	1.44M	961K
Research and Development Revenue Growth	+84.20%	-63.56%	+129.06%	+7.66%	+12.62%	+3.05%	+15.65%	+6.95%	+18.08%	-2.33%	+50.37%	-65.58%	+342.52%	-0.66%	-21.52%	+203.29%	+64.17%	+76.55%	+49.53%	n/a